fda category 2 bulk drug substances bpc-157 Regulatory Alert: The Legal Status of in Compounding and Clinical Practice – Holt Law BPC-157 After the April 2026

Bleeding is a potential complication that can occur with any kind of injection

Last September, the FDA reclassified BPC-157 , epitalon , GHK-Copper , and thymosin alpha-1 along with 13 other commonly used therapeutic peptides, adding them to the Category 2 Bulk Drug Substance list

Clinicians should not assume the result is always falsely low

(Anyone classed as seriously deficient should see a doctor and may need B12 injections)

In preclinical models, HGH Fragment 176-191 has been studied primarily via subcutaneous administration

It is usually administered in a healthcare setting, such as Neighborhood Medical Center, and the injection is typically given in the muscle (intramuscular, IM) or under the skin (subcutaneously)